Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WD repeat domain 86 (WDR86) is a protein coding gene that belongs to the WD repeat domain-containing protein family, characterized by tandem repeats that typically form a β-propeller structure facilitating protein-protein interactions[1][3][5][6]. It is expressed in many human tissues, with no distinct tissue specificity, and is not currently known to function as a receptor, enzyme, transporter, or transcription factor[4][7]. Diseases such as hypophosphatasia have been noted in association datasets, but no concrete evidence links WDR86 mechanistically to disease causation or progression. There are no known drugs, validated disease biomarkers, or established safety concerns related to WDR86 at present[4]. The canonical name and abbreviation are correct and consistent in major biological databases. If you need further structured information or have therapeutic context, additional molecular functional studies may be required because current data is limited to gene/protein annotation and indirect disease associations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WD repeat domain 86 (WDR86).